【诺和诺德(NVO.US)Wegovy减肥药登陆印度,落后礼来数月进场】智通财经APP获悉,在落后竞争对手礼来(LLY.

智通财经
24 Jun
【诺和诺德(NVO.US)Wegovy减肥药登陆印度,落后礼来数月进场】智通财经APP获悉,在落后竞争对手礼来(LLY.US)数个月后,丹麦制药巨头诺和诺德(NVO.US)终于进入印度这个全球人口第一大国。诺和诺德表示,将在印度销售其畅销的减肥药物Wegovy。该药物已在印度获批用于长期慢性体重管理及降低重大心血管不良事件的风险。截至发稿,诺和诺德周二美股盘前涨逾2%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10